Petros Pharmaceuticals, Inc. (PTPI) — 8-K Filings

8-K Filings (17)

• Petros Pharmaceuticals Faces Delisting Notice — Nov 7, 2025 Risk: high
  Petros Pharmaceuticals, Inc. filed an 8-K on November 7, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, effec
• Petros Pharma Changes Auditors to Marcum LLP — Sep 5, 2025 Risk: medium
  Petros Pharmaceuticals, Inc. announced on August 29, 2025, a change in its certifying accountant. The company has dismissed its previous independent registered
• Petros Pharmaceuticals Files 8-K — Jun 20, 2025 Risk: low
  Petros Pharmaceuticals, Inc. filed an 8-K on June 20, 2025, reporting an event on June 16, 2025. The filing is a current report under Regulation FD and includes
• Petros Pharma Faces Delisting Concerns — May 21, 2025 Risk: high
  Petros Pharmaceuticals, Inc. filed an 8-K on May 21, 2025, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The compa
• Petros Pharmaceuticals Faces Delisting Concerns — May 2, 2025 Risk: high
  Petros Pharmaceuticals, Inc. filed an 8-K on May 2, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing
• Petros Pharma Faces Delisting Concerns, Files 8-K — Apr 11, 2025 Risk: high
  On April 8, 2025, Petros Pharmaceuticals, Inc. filed an 8-K to report several significant events. These include a notice of potential delisting or failure to me
• Petros Pharmaceuticals Files 8-K on Accountant Change — Apr 9, 2025 Risk: low
  Petros Pharmaceuticals, Inc. filed an 8-K on April 9, 2025, reporting changes in its certifying accountant and filing financial statements and exhibits. The rep
• Petros Pharmaceuticals Files 8-K — Feb 21, 2025 Risk: medium
  On February 17, 2025, Petros Pharmaceuticals, Inc. entered into a material definitive agreement. The company also reported other events and filed financial stat
• Petros Pharma Files 8-K on Material Agreements — Jan 24, 2025 Risk: medium
  Petros Pharmaceuticals, Inc. filed an 8-K on January 24, 2025, reporting on events that occurred on January 23, 2025. The filing indicates a material definitive
• Petros Pharma 8-K: Financial Obligation Trigger Event — Dec 16, 2024 Risk: medium
  On December 10, 2024, Petros Pharmaceuticals, Inc. filed an 8-K report to disclose a triggering event related to its financial obligations. The filing indicates
• Petros Pharmaceuticals Files 8-K on Shareholder Votes — Nov 21, 2024 Risk: low
  Petros Pharmaceuticals, Inc. filed an 8-K on November 20, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain sp
• Petros Pharma Board & Executive Changes Announced — Oct 18, 2024 Risk: medium
  Petros Pharmaceuticals, Inc. announced on October 16, 2024, a change in its board of directors and executive compensation arrangements. The filing details the d
• Petros Pharmaceuticals Files 8-K for Material Agreement — Oct 17, 2024 Risk: medium
  Petros Pharmaceuticals, Inc. announced on October 11, 2024, that it entered into a material definitive agreement. The company also reported modifications to the
• Petros Pharma Appoints New CMO, Elects Director — Oct 4, 2024 Risk: medium
  Petros Pharmaceuticals, Inc. announced on October 1, 2024, the appointment of Dr. Fady Malik as Chief Medical Officer and the election of Ms. Jennifer Choe to i
• Petros Pharma Files 8-K on Shareholder Nominations — Sep 19, 2024 Risk: medium
  Petros Pharmaceuticals, Inc. filed an 8-K on September 19, 2024, reporting shareholder nominations pursuant to Exchange Act Rule 14a-11 as of September 16, 2024
• Petros Pharmaceuticals Enters Material Definitive Agreement — Mar 22, 2024 Risk: medium
  On March 21, 2024, Petros Pharmaceuticals, Inc. entered into a material definitive agreement. The filing also includes financial statements and exhibits related
• Petros Pharma Changes Certifying Accountant, Effective Jan 8 — Jan 12, 2024
  Petros Pharmaceuticals, Inc. (PTPI) filed an 8-K on January 12, 2024, reporting a change in its certifying accountant, effective January 8, 2024. This means the

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX